HIV

Study targets how HIV avoids immune system defenses.

Research evaluates how HIV evades immune system detection.

Researchers seek to develop drugs that block the Nef protein that is associated with HIV progressing to AIDS.

Patients taking mediations for both HIV and HCV must be closely monitored for drug-drug interactions.

Study will be the first to evaluate the role of metformin on liver fibrosis in HCV-HIV co-infected and HCV mono-infected patients.

Drug resistance not found to increase among patients with HIV.

Researchers explore harnessing power of immune system to kill HIV.

HIV-positive men were more likely to have increased levels of inflammatory biomarkers than HIV-negative men.

School-based health services provide critical preventive care for adolescents, especially in poor and diverse communities.

Research analyzes HIV-positive individuals who naturally produce broadly neutralizing antibodies.

Simian immunodeficiency virus may be able to infect human cells.

Through a shell company, a New York pharmacist improperly billed Medicaid and others $274 million for illegally obtained HIV drugs.

Many conventional tests unable to detect resistance to antiretroviral drugs for HIV.

Athletes from a variety of sports dealt with the hardships of diseases treated by specialty pharmacy.

Receiving early ART associated with a 316-fold decrease in HIV DNA after 3 years.

Anti-PD-1 antibodies produced more activated antiviral cells to attack HIV.

HIV screenings at home and immediate administration of antiretroviral therapy in HIV-positive patients shows promise.

It was previously believed that HIV-related brain inflammation may prevent Alzheimer’s disease.

Increased life expectancy for HIV-positive patients spurs the need to discuss advanced care planning.

Resistance development has been minimal under the controlled high adherence conditions of clinical trials. However, real-world adherence is less consistent.

Treatment with Truvada highly effective in reducing the risk of HIV.

Top news of the day from across the health care landscape.

Chimeric antigen receptors, typically studied for cancer immunotherapy, may treat HIV.

Researchers seek to eliminate HIV reservoirs with antiretroviral therapy.

Breastfed Infants with an HIV-positive mother had an altered microbiome.